Regeneron Acquires 23andMe for 6 Million Following Bankruptcy Proceedings
Regeneron Pharmaceuticals has announced a significant acquisition, purchasing genetic testing company 23andMe for 6 million through a bankruptcy auction. Once valued at a remarkable billion, 23andMe is best known for its at-home saliva testing kits that have allowed approximately 15 million individuals to explore their genetic makeup. With this acquisition, Regeneron aims to enhance its…
